Yasuo Fujii

Direktör/Styrelseledamot på ORCHARD THERAPEUTICS PLC

Health Technology

Consumer Services

Profil

Yasuo Fujii is Director at Orchard Therapeutics Plc since 2024.
Mr. Fujii is Chief Strategy Officer at Kyowa Kirin Co., Ltd. since 2023.
Formerly, Mr. Fujii was Executive Vice President-Corporate Planning at Kyowa Kirin International Plc.
Mr. Fujii earned an MBA from the University of Illinois.

Aktiva positioner av Yasuo Fujii

Företag	Position	Start
KYOWA KIRIN CO., LTD.	Företagsledare/Principal	1988-04-01
ORCHARD THERAPEUTICS PLC	Direktör/Styrelseledamot	2024-01-24

Alla aktiva positioner av Yasuo Fujii

Tidigare kända positioner av Yasuo Fujii

Företag	Position	Slut
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Företagsledare/Principal	-

Se detaljerna i Yasuo Fujiis erfarenhet

Yasuo Fujiis utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Yasuo Fujiis erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Health Technology
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology